SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins

Ulcerative Colitis Clinical Trial

Official title:

Non Genetic Factors in the Pathogenesis of Inflammatory Bowel Disease in Twins

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02383953
• Other study ID #: SSAT 054
• Status: Active, not recruiting
• Phase: N/A
• First received: January 7, 2015
• Last updated: October 25, 2017
• Start date: May 2015
• Est. completion date: October 2017

Study information

• Verified date: October 2017
• Source: St Stephens Aids Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to investigate the role of non-genetic factors in the pathogenesis of inflammatory bowel disease.An exploratory study to investigate differences between the epigenome, microbiota and functional immunology in twins discordant for inflammatory bowel disease.

Description:

Background: The inflammatory bowel diseases (IBD), Crohn's Disease (CD) and Ulcerative Colitis (UC), are debilitating conditions with a complex aetiology. The biggest risk factor for developing IBD is having an affected first degree relative. However when an identical twin is diagnosed with IBD, the other twin goes on to develop the condition in only 20-55% of cases.

Recent research suggests the microbiota the ecosystem of bacteria within the gut may trigger disease in susceptible individuals. Another important research area is the epigenome changes to the structure and regulation of our genome which occur throughout our life. It is known that siblings of Crohn's Disease sufferers have a changes to the immune system characteristic of Crohn';s. However it is not known whether these changes are due to genetic similarity or shared environment. Comparison between mono and dizygotic twins elucidates the relative importance of genetic and environmental factors.

Primary Objective: An exploratory study to investigate differences between the epigenome, microbiota and functional immunology in twins discordant for inflammatory bowel disease.

Study Design: Multicentre basic science study involving human participants

Planned sample size: 200 data subjects (100 twin pairs)

Methodology:

A) Identification of twin pairs where one or both have inflammatory bowel disease via:

1. IBD Nixon Twin and Multiplex Registry.

2. Advertising for twin pairs via BSG website and newsletters/patient support groups/social media sites/clinic posters.

3. Identification by study sites B) Obtaining formal written consent C) Collection of blood, stool and urine.

D) The following analysis will be carried out:

• Epigenetics (blood) DNA extraction and subsequent methylation analysis and bisulphate conversion with 450 Illumina beadchip assay

• Functional immunology (blood) - flow cytometry of CD3, CD4 and CD8 cells. (London Twin pairs discordant for Crohn's Disease)

• 16S rRNA gene sequencing (stool) - of bacterial DNA

• Metabolomic profiling (Urine and stool) - using Nuclear Magnetic Resonance (NMR) and mass spectrometry E) Collection of dietary history information for the previous 72hr period Study Duration: 2 years (single visit).

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 200
• Est. completion date: October 2017
• Est. primary completion date: October 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Monozygotic twins discordant for IBD

• Monozygotic twins concordant for IBD

• Dizygotic twins discordant for IBD

• Dizygotic twins concordant for IBD

• Healthy controls

Exclusion Criteria:

• <18 years old

• Antibiotics within past 3 months of sample collection

• Unable to give informed consent

Related Conditions & MeSH terms

• Colitis, Ulcerative
• Crohn Disease
• Crohn's Disease
• Inflammatory Bowel Disease
• Inflammatory Bowel Diseases
• Intestinal Diseases
• Ulcerative Colitis

Locations

Country	Name	City	State
United Kingdom	Chelsea and Westminster Hosptial	London

Sponsors (1)

Lead Sponsor	Collaborator
St Stephens Aids Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Difference in DNA methylation patterns between twin pairs		1 day (1 visit only)
Primary	Difference in microbiota composition and metabolomic profiles between IBD phenotypes		1 day (1 visit only)
Primary	Comparison of microbiota composition and metabolic profiles with DNA methylation patterns		1 day (1 visit only)
Primary	Difference in T cell phenotypes and antigen presenting cells between twin pairs discordant for IBD		1 day (1 visit only)